BrainsWay Expands Mental Health Treatment Across the U.S.
BrainsWay Expands Mental Health Treatment Across the U.S.
BrainsWay Ltd. (NASDAQ: BWAY), a pioneering firm in noninvasive neurostimulation therapies, has marked a significant milestone with an ambitious expansion of its Deep TMS™ platform on the East Coast. The announcement came as the company confirmed an order of 14 new Deep TMS systems from a large enterprise network dedicated to mental health care. This order not only emphasizes BrainsWay's growing influence but also solidifies its position as a go-to provider among health practitioners.
CEO Comments on Expansion Strategy
“We are enthusiastic about enhancing the accessibility of Deep TMS therapy across the East Coast,” stated Hadar Levy, BrainsWay’s Chief Executive Officer. The order reflects a firm commitment to ushering in technologically advanced treatment options that benefit patients. Levy highlighted that nurturing relationships with diverse mental health organizations is crucial for achieving sustainable growth.
Current Success and Installed Base
As of mid-2024, BrainsWay boasts an installed base of over 1,200 Deep TMS systems across various locations. This extensive reach showcases the effectiveness and acceptance of this innovative treatment modality in addressing complex mental health disorders.
About Deep TMS Therapy
Deep Transcranial Magnetic Stimulation (Deep TMS™) represents a groundbreaking approach in treating mental health disorders such as major depressive disorder, obsessive-compulsive disorder, and smoking addiction. BrainsWay is proudly acknowledged for being the first company in the TMS sector to obtain FDA clearance for multiple indications, backed by substantial clinical research proving its efficacy. The technology utilizes magnetic fields to stimulate targeted areas of the brain, offering hope to patients seeking alternative treatment options.
Commitment to Continued Research and Development
BrainsWay is committed to advancing the science of neurostimulation. The company actively engages in clinical trials focusing on various psychiatric and neurological conditions. With its ongoing studies, BrainsWay aims to broaden treatment applications and reaffirm its leadership position in the neurostimulation field.
Building Awareness and Access
Founded in 2003 with headquarters in Burlington, MA, and Jerusalem, Israel, BrainsWay continues to work towards increasing global awareness regarding Deep TMS therapy. By ensuring greater accessibility, the company aspires to make a real difference in the lives of individuals battling mental health challenges.
Engagement with Investors and Stakeholders
The success of BrainsWay is attributed to its dedicated team and the ongoing engagement with investors and stakeholders. The company emphasizes transparency and is committed to updating its partners about significant developments, like the recent expansion efforts.
Frequently Asked Questions
What is Deep TMS therapy?
Deep TMS therapy is a noninvasive treatment that uses magnetic fields to stimulate specific areas in the brain, primarily aimed at treating mental health disorders.
How has BrainsWay expanded its reach recently?
BrainsWay has expanded its presence in the U.S. by securing a large order for 14 Deep TMS systems from an enterprise network focused on mental health.
What are the FDA-cleared indications for Deep TMS?
The FDA has cleared Deep TMS for several conditions including major depressive disorder, obsessive-compulsive disorder, and smoking addiction.
Where can I learn more about BrainsWay?
For the latest updates and information about BrainsWay, you can visit their official website.
How many Deep TMS systems are currently installed?
As of June 30, 2024, BrainsWay had installed over 1,215 Deep TMS systems worldwide.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.